October 10, 2016 / 6:21 AM / 9 months ago

BRIEF-Pfizer announces results from Phase 3 S-TRAC clinical trial

1 Min Read

Oct 10 (Reuters) - Pfizer Inc :

* Press release - first positive phase 3 results in adjuvant setting for renal cell carcinoma show sutent (sunitinib) extended disease free survival after surgical removal

* First positive phase 3 results in adjuvant setting for renal cell carcinoma show sutent (sunitinib) extended disease free survival after surgical removal

* Says based on results of s-trac, Pfizer is in discussions with global regulatory authorities to determine potential next steps.

* Says adverse events seen in trial were consistent with sutent's known safety profile Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below